Ruggeri, Marco Stefano
 Distribuzione geografica
Continente #
NA - Nord America 184
EU - Europa 138
AS - Asia 90
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 416
Nazione #
US - Stati Uniti d'America 183
CN - Cina 86
GB - Regno Unito 41
IE - Irlanda 24
FR - Francia 22
SE - Svezia 22
DE - Germania 10
IT - Italia 7
UA - Ucraina 7
FI - Finlandia 5
VN - Vietnam 4
BR - Brasile 1
CA - Canada 1
CL - Cile 1
EU - Europa 1
PE - Perù 1
Totale 416
Città #
Chandler 45
Southend 40
Jacksonville 30
Dublin 24
New York 21
Beijing 16
Lawrence 10
Princeton 10
Tianjin 8
Wilmington 8
Jinan 7
Nanjing 7
Shenyang 7
Hebei 6
Ashburn 5
Hangzhou 5
Helsinki 5
Dong Ket 4
Grafing 4
Haikou 4
Taiyuan 4
Dearborn 3
Fuzhou 3
Norwalk 3
Sindelfingen 3
Changsha 2
Guangzhou 2
Lanzhou 2
Milan 2
Ningbo 2
Redwood City 2
Seattle 2
Taizhou 2
Zhengzhou 2
Cambridge 1
Chicago 1
Fairfield 1
Grossmuehlingen 1
Jiaxing 1
Lima 1
Ludwigshafen am Rhein 1
Nanchang 1
Redmond 1
Speyer 1
São Paulo 1
Toronto 1
Vigasio 1
Totale 313
Nome #
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C? 58
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases 52
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia 49
The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemia 46
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi 46
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 43
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study 39
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 37
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 36
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 21
Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice 1
Totale 428
Categoria #
all - tutte 1.834
article - articoli 1.834
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 0 5
2019/202052 9 0 0 0 8 8 3 7 1 5 3 8
2020/202198 14 20 2 22 11 10 0 1 2 2 8 6
2021/202259 6 12 2 4 1 1 5 5 0 1 4 18
2022/2023147 11 17 18 13 15 36 4 8 19 0 4 2
2023/202459 5 6 3 6 10 20 5 4 0 0 0 0
Totale 428